About
Basic Data Updated:
1 month agoThe Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 cr and a paid-up capital of Rs 1.00 cr.
The Corporate currently has active open charges totaling ₹4.06 cr.
Rajesh Kaul and Ruby Gogia serve as directors at the Company.
Industry
Company Details
- Location
New Delhi, Delhi, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U51109DL2015PTC286671 |
| Company No. | 286671 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 21 Oct 2015 |
| Date of AGM | 28 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Products or Services related to Mediart Lifesciences Private Limited
Kidney Drugs
Multivitamin Tablets & Capsules
Immunosuppressive Drugs
Kidney Care
Financials of Mediart Lifesciences Private Limited
Mediart Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.48% increase. The company also saw a slight improvement in profitability, with a 8.9% increase in profit. The company's net worth Soared by an impressive increase of 10.7%.
Corporate Structure
Unlock access to Mediart Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Mediart Lifesciences Private Limited
Unlock and access historical data on people associated with Mediart Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Aug 2020 | ₹4.06 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediart Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediart Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Charges
A charge with Hdfc Bank Limited of Rs. 4.06 cr registered on 26 Aug 2020 with Charge ID 100366915 was modified on 28 Jun 2024.
28 Jun 2024Annual General Meeting
Mediart Lifesciences Private Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records.
28 Sep 2023Balance Sheet
Mediart Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.06 cr with Charge ID 100366915 was registered on 26 Aug 2020.
26 Aug 2020Director Appointment
Ruby Gogia was appointed as a Director was appointed as a Director on 03 Sep 2016 & has been associated with this company since 8 years 19 days .
03 Sep 2016
Frequently asked questions
What is the Incorporation or founding date of Mediart Lifesciences Private Limited?
